Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander L Miller

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Psychiatric Services (Washington, D.C.)|September 4, 2007
Relationships among subjective and objective measures of adherence to oral antipsychotic medicationsDawn I Velligan, Mei Wang, Pamela Diamond, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 10, 2007
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophreniaDonald C Goff, J Steven Lamberti, Andrew C Leon, et al.
Psychiatric Services (Washington, D.C.)|May 6, 2006
An empirical analysis of cost outcomes of the Texas Medication Algorithm ProjectT Michael Kashner, A John Rush, M Lynn Crismon, et al.
Schizophrenia Bulletin|October 13, 2007
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophreniaDawn I Velligan, Pamela M Diamond, Jim Mintz, et al.
Administration and Policy in Mental Health|February 28, 2009
Scales to evaluate quality of medication management: development and psychometric propertiesAmanda C Taylor, Gary R Bond, Jack Tsai, et al.
Bipolar Disorders|February 16, 2011
Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal studyOlga C Chaves, Lauren E Lombardo, Carrie E Bearden, et al.
The American Journal of Psychiatry|September 26, 2017
Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based InterventionDelbert G Robinson, Nina R Schooler, Christoph U Correll, et al.
Psychiatric Services (Washington, D.C.)|July 28, 2006
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trialMiranda H Chakos, Ira D Glick, Alexander L Miller, et al.
Schizophrenia Research|November 26, 2008
Results of phase 3 of the CATIE schizophrenia trialT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Schizophrenia Research|October 12, 2004
A brief cognitive assessment for use with schizophrenia patients in community clinicsDawn I Velligan, Margaret DiCocco, C Christine Bow-Thomas, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Psychiatric Services (Washington, D.C.)|September 4, 2007
Relationships among subjective and objective measures of adherence to oral antipsychotic medicationsDawn I Velligan, Mei Wang, Pamela Diamond, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 10, 2007
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophreniaDonald C Goff, J Steven Lamberti, Andrew C Leon, et al.
Psychiatric Services (Washington, D.C.)|May 6, 2006
An empirical analysis of cost outcomes of the Texas Medication Algorithm ProjectT Michael Kashner, A John Rush, M Lynn Crismon, et al.
Schizophrenia Bulletin|October 13, 2007
The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophreniaDawn I Velligan, Pamela M Diamond, Jim Mintz, et al.
Administration and Policy in Mental Health|February 28, 2009
Scales to evaluate quality of medication management: development and psychometric propertiesAmanda C Taylor, Gary R Bond, Jack Tsai, et al.
Bipolar Disorders|February 16, 2011
Association of clinical symptoms and neurocognitive performance in bipolar disorder: a longitudinal studyOlga C Chaves, Lauren E Lombardo, Carrie E Bearden, et al.
The American Journal of Psychiatry|September 26, 2017
Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based InterventionDelbert G Robinson, Nina R Schooler, Christoph U Correll, et al.
Psychiatric Services (Washington, D.C.)|July 28, 2006
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trialMiranda H Chakos, Ira D Glick, Alexander L Miller, et al.
Schizophrenia Research|November 26, 2008
Results of phase 3 of the CATIE schizophrenia trialT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Schizophrenia Research|October 12, 2004
A brief cognitive assessment for use with schizophrenia patients in community clinicsDawn I Velligan, Margaret DiCocco, C Christine Bow-Thomas, et al.
Pageof 7